Innoviva, Inc. — Director's Dealing 2013

Jan 15, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2013-01-11

Reporting Person: Mammen Mathai (SVP, Research & Early Clin Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-01-11	Common Stock	M	11855	$3.10	Acquired	217783	Direct
2013-01-11	Common Stock	M	2655	$3.10	Acquired	220438	Direct
2012-12-31	Common Stock	G	460	—	Disposed	219978	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-11	Stock Option (Right to Buy)	$3.10	M	11855	Disposed	2013-01-23	Common Stock (11855)	Direct
2013-01-11	Stock Option (Right to Buy)	$3.10	M	2655	Disposed	2013-01-23	Common Stock (2655)	Direct

Footnotes

F1: Immediately exercisable.